CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
Biofeedback Interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03273673
NCT03273673N/ACompleted
CompareCT.gov

Reduction of Risk Factors for ACL Re-injuries Using an Innovative Biofeedback Approach

Virginia Polytechnic Institute and State University·interventional·Posted Sep 6, 2017·Updated Dec 4, 2020

In Brief

A clinical study evaluating Biofeedback Intervention for Anterior Cruciate Ligament Injury. Completed, enrolled 40 participants across 1 site.

Detailed Summary

ACL injuries are common among athletes and due to residual muscle weakness, limited knee motion and asymmetrical movement patterns after surgery many of these athletes will sustain secondary ACL injuries following return to sports. This project seeks to determine if a novel biofeedback-based rehabilitation approach can decrease a known risk factor for secondary injuries to the ACL. The project specifically focuses on correcting asymmetric movement patterns, a known risk factor for secondary injury that is not directly addressed by existing interventions through a 6 week therapy based biofeedback intervention.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnterior Cruciate Ligament Injury
CountriesUnited States
CollaboratorsNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedSep 6, 2017
Enrollment StartMar 20, 2018
Primary CompletionMay 5, 2020
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 8.8 years ago

Interventions

Biofeedback Interventionother

Visual and Tactile Biofeedback